---
title: Five Key Takeaways From FDA’s CBD Public Meeting
date: 2019-06-06T07:25:57-04:00
author: Import Bot
canonical_url: "https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/five-key-takeaways-from-fdas-cbd-public-meeting"
section: Blog Posts
---
# Five Key Takeaways From FDA’s CBD Public Meeting

 Kelley Drye 

 June 6, 2019

 

 

 

 

 

 

With CBD projected to be a $450 Million industry in the coming year, FDA hosted a packed house of industry stakeholders last week in a day-long public meeting that was the kickoff of a discussion to determine whether there is a pathway for CBD in ingestible products such as foods and dietary supplements. See our [summary of key themes here](https://www.fooddruglaw.com/2019/06/01/fda-cbd-public-meeting-features-overwhelming-calls-for-robust-regulation-and-enforcement-relaxation-of-obstacles-to-research/) and check out [this podcast episode](https://podcasts.apple.com/us/podcast/cbd-five-key-takeaways-from-fdas-cbd-public-meeting/id1457734764?i=1000440706868) to hear five key takeaways.

 

 **Tags:** [Cannabidiol (CBD)](https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/tags/cannabidiol-cbd)

 

 - Share this entry 
    - 
    - 
    - 
    -
- [  View entry pdf ](https://s3.amazonaws.com/cdn.kelleydrye.com/content/uploads/pdf-snapshots/five-key-takeaways-from-fdas-cbd-public-meeting-20240523151731.pdf)
 
 

### Search Blog

  

### Subscribe

  

### Explore Topics

- [Dietary Supplements](https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/dietary-supplements)
 
 

### Related Services

- [Advertising and Marketing](https://www.kelleydrye.com/practices/advertising-and-marketing)